Patents by Inventor Ivan Zanoni

Ivan Zanoni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240366594
    Abstract: Described herein are compositions and methods that inhibit class I and IIb HIDACs for use in inhibiting NETosis and conditions associated with NETosis.
    Type: Application
    Filed: May 27, 2022
    Publication date: November 7, 2024
    Inventors: Jeffrey M. Karp, Ivan Zanoni, Pui Yan Ma, Ralph Mazitschek, Stephen J. Haggarty
  • Publication number: 20240148864
    Abstract: Provided herein are adjuvantation systems comprising fungal polysaccharides for use in Beta coronavirus (e.g., MERS-CoV, SARS-CoV-1, or SARS-CoV-2) and influenza (influenza A virus and influenza B virus) vaccines and immunogenic compositions comprising the adjuvantation system and a Beta coronavirus or influenza virus antigen.
    Type: Application
    Filed: March 11, 2022
    Publication date: May 9, 2024
    Applicant: Children's Medical Center Corporation
    Inventors: Ivan Zanoni, Francesco Borriello, Ofer Levy, David J. Dowling
  • Publication number: 20150224061
    Abstract: The present invention relates to methods and means of transport of active substances in the cell cytosol. In particular, the invention relates to means that make it possible to transport directly in the cytosol substances capable of interacting with protein systems, such as the family of nuclear factors of activated T-cells (NFATs) or nucleic acids localized in the cytosol. In particular, the invention relates to nanoconstructs useful in the treatment of inflammatory diseases, methods for their preparation, and compositions containing them.
    Type: Application
    Filed: July 19, 2013
    Publication date: August 13, 2015
    Inventors: Francesca Granucci, Davide Prosperi, Ivan Zanoni, Fabio Ruggero Maria Corsi, Miriam Colombo